staceywhite, Author at European Medical Journal - Page 38 of 195

EAN 2024 Interview: Thomas Berger

Originally, I wanted to get into tropical medicine. However, Vienna is not a core site for tropical medicine. By chance, there was a call…

Interview: Carlo La Vecchia

When I graduated from Oxford in the early 80s, epidemiology was a key, innovative discipline. There were several important discoveries at…

Interview: Patricia Silveyra

Patricia Silveyra: Associate Professor and Chair, Department of Environmental and Occupational Health, Indiana University, Bloomington…

Leukaemia: CAR-T Cell Therapy Innovations

This infographic explores the use of CAR-T cell therapy for leukemia, it touches on the mechanism of this therapy, benefits and potential…

TET2 Mutations Affect Stem Cell Response to Immune Stress

Understanding how loss of function mutation of TET2 in haematopoietic stem cells (HSC) changes their response to stress is crucial to…

Impact of Normalisation of Haemostasis for People with Haemophilia A

Explore insights on the normalisation of haemostasis in people with Haemophilia A, featuring highlights from the Sobi symposium at EHA 2024

The latest issue of EMJ Rheumatology

The new edition of EMJ Rheumatology features insights from this year’s European Alliance of Associations for Rheumatology Congress.

Effects of High-Intensity Resistance Training for Patients with Myositis

Reduced muscle endurance and strength are cardinal traits in patients with myositis. These traits are associated with reduced quality of…

Therapeutic Approaches for Platelet Disorders

Read on to learn more about Lowe syndrome, Bernard Soulier disease, and TAR syndrome among others in this infographic.

KMT2A-MLLT3-Induced Leukaemia Changes During Ontogenic Stages

The KMT2A-MLLT3 (also known as MLL-AF9) fusion is associated with acute lymphoid leukaemia (ALL), acute myeloid leukaemia (AML), and mixed…